Inventor profile of:

David KIRN

City:

Mill Valley, California

Country:

United States

Published Applications:

15

Last publication date:

2021-10-21

Top Assignees for applications by David KIRN

The entities that hold a legal rights for patent applications filed by inventor KIRN David:

Recent patent applications by KIRN David

David KIRN from Mill Valley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-10-21
US20210322578A1
Human necessities

ONCOLYTIC VACCINIA VIRUS CANCER THERAPY

#2 | 2020-01-09
US20200009269A1
Human necessities

ONCOLYTIC VACCINIA VIRUS CANCER THERAPY

#3 | 2019-06-06
US20190169578A1
Chemistry; metallurgy

Methods and compositions for production of vaccina virus

#4 | 2018-09-13
US20180256751A1
Human necessities

ONCOLYTIC VACCINIA VIRUS CANCER THERAPY

#5 | 2018-08-02
US20180214538A1
Human necessities

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

#6 | 2017-10-19
US20170298324A1
Chemistry; metallurgy

Methods and compositions for production of vaccinia virus

#7 | 2016-02-11
US20160038548A1
Human necessities

Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses

#8 | 2015-02-05
US20150037355A1
Human necessities

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

#9 | 2014-10-30
US20140322173A1
Human necessities

Oncolytic vaccinia virus combination cancer therapy

#10 | 2013-07-18
US20130183271A1
Human necessities

Methods and compositions concerning poxviruses and cancer

#11 | 2010-12-02
US20100303714A1
Chemistry; metallurgy

ONCOLYTIC VACCINIA VIRUS CANCER THERAPY

#12 | 2009-01-01
US20090004723A1
Human necessities

Methods and compositions concerning poxviruses and cancer

#13 | 2008-11-20
US20080286237A1
Human necessities

Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses

#14 | 2007-03-22
US20070065411A1
Human necessities

Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses

#15 | 2006-05-11
US20060099224A1
Human necessities

Methods and compositions concerning poxviruses and cancer

InventorID:

343903 ⎘